Last reviewed · How we verify
Dipeptidyl Peptidase 4 Inhibitor — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Dipeptidyl Peptidase 4 Inhibitor (Dipeptidyl Peptidase 4 Inhibitor) — Changhua Christian Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dipeptidyl Peptidase 4 Inhibitor TARGET | Dipeptidyl Peptidase 4 Inhibitor | Changhua Christian Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dipeptidyl Peptidase 4 Inhibitor CI watch — RSS
- Dipeptidyl Peptidase 4 Inhibitor CI watch — Atom
- Dipeptidyl Peptidase 4 Inhibitor CI watch — JSON
- Dipeptidyl Peptidase 4 Inhibitor alone — RSS
Cite this brief
Drug Landscape (2026). Dipeptidyl Peptidase 4 Inhibitor — Competitive Intelligence Brief. https://druglandscape.com/ci/dipeptidyl-peptidase-4-inhibitor. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab